Helix Acquisition (NASDAQ:HLXA) Stock Price Up 2.7%

Helix Acquisition Corp. (NASDAQ:HLXA – Get Rating)’s stock price rose 2.7% on Thursday . The stock traded as high as $5.38 and last traded at $5.30. Approximately 2,926 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 89,000 shares. The stock had previously closed at $5.16.

The firm’s fifty day moving average is $5.79 and its two-hundred day moving average is $8.48.

In related news, major shareholder Bihua Chen purchased 2,850,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 5th. The shares were acquired at an average price of $10.00 per share, for a total transaction of $28,500,000.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Several hedge funds have recently made changes to their positions in the company. RPO LLC bought a new stake in shares of Helix Acquisition during the 4th quarter valued at $135,000. Ergoteles LLC purchased a new position in shares of Helix Acquisition in the 1st quarter worth about $162,000. OMERS ADMINISTRATION Corp purchased a new position in shares of Helix Acquisition in the 1st quarter worth about $513,000. Fir Tree Capital Management LP purchased a new position in shares of Helix Acquisition in the 1st quarter worth about $619,000. Finally, Iron Park Capital Partners LP purchased a new position in shares of Helix Acquisition in the 4th quarter worth about $615,000.

Helix Acquisition Company Profile (NASDAQ:HLXA)

As of April 5, 2022, Helix Acquisition Corp. was acquired by MoonLake Immunotherapeutics AG, in a reverse merger transaction. Helix Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities.

See Also